Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1B | P28222 | 3/20 | 0.58 |
| ▸ | MAOA | P21397 | 4/20 | 0.57 |
| ▸ | TOP2A | P11388 | 3/20 | 0.49 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | HTR1D | P28221 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5749002 | 0.96 | MAOA (0.56) | HTR1BMAOATOP2ACYP2A6NPC1 | |
| SCHEMBL5749598 | 0.91 | MAOA (0.58) | HTR1BMAOATOP2ACYP2A6NPC1 | |
| SCHEMBL5748395 | 0.90 | HTR1B (0.63) | HTR1BMAOACYP2A6ADRB2KDM4E | |
| SCHEMBL5749070 | 0.88 | MAOA (0.57) | HTR1BMAOATOP2ACYP2A6NPC1 | |
| SCHEMBL5748123 | 0.86 | HTR1B (0.59) | HTR1BMAOACYP2A6ADRB2KDM4E | |
| SCHEMBL5749472 | 0.86 | MAOA (0.61) | HTR1BMAOACYP2A6NPC1MEN1 | |
| SCHEMBL5748338 | 0.86 | HTR1B (0.58) | HTR1BCYP2A6KMT2AADRB2KDM4E | |
| SCHEMBL5748462 | 0.85 | MAOA (0.59) | HTR1BMAOACYP2A6NPC1MEN1 | |
| SCHEMBL28198664 | 0.84 | MAOA (0.62) | MAOATOP2ACYP2A6NPC1KDM4E | |
| SCHEMBL7332273 | 0.82 | TOP2A (0.70) | MAOATOP2AADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1711463-A2 | AMINO-SUBSTITUTED TRICYCLIC DERIVATIVES AND METHODS OF USE | ABBOTT LABORATORIES (US) | 2006-10-18 | — | — | EP | disclosed |
| WO-2005077899-A2 | AMINO-SUBSTITUTED TRICYCLIC DERIVATIVES AND METHODS OF USE | ABBOTT LABORATORIES (US) | 2005-08-25 | — | — | WO | disclosed |